Loading...

Scinai Immunotherapeutics Ltd.

SCNI•NASDAQ
Healthcare
Biotechnology
$0.74
$0.28(61.62%)
U.S. Market opens in 13h 42m

Scinai Immunotherapeutics Ltd. (SCNI) Stock Overview

Explore Scinai Immunotherapeutics Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap987.2K
P/E Ratio-0.20
EPS (TTM)$4.00
ROE-0.98%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.12
3 Months$0.00
1 Year Target$3.09

SCNI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scinai Immunotherapeutics Ltd. (SCNI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.95, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.20 and a market capitalization of 987.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
61.62%
5-Day Change
22.83%
1-Month Change
9.41%
3-Month Change
-26.26%
6-Month Change
-49.52%
Year-to-Date (YTD) Change
3.50%
1-Year Change
-69.55%
3-Year Change
-96.14%
5-Year Change
-99.78%
All-Time (Max) Change
-99.85%

Contact Information

https://www.scinai.com
972 8 930 2529
Jerusalem BioPark Building, Jerusalem, NaN, NaN

Company Facts

31 Employees
IPO DateMay 11, 2015
CountryIL
Actively Trading

Frequently Asked Questions